Kids Channel
Related Channels

Synagis RSV Prophylaxis

By preventing serious complications in children who have a high risk for problems with respiratory syncytial virus (RSV), Synagis® (palivizumab) can be a beneficial prophylaxis (a measure used to prevent severe medical problems). This medication is prescribed to infants and children age 24 months and younger. It cannot prevent a child from getting an RSV infection, but it can help prevent the infection from becoming so severe that it would cause potentially dangerous problems.
Synagis comes as an injection that is given into a muscle once a month. It is designed to help prevent RSV complications in infants and children who have a high risk for these problems. Some of these high-risk cases include children or infants who were premature or who have certain types of lung or heart disease.
(For more information on this RSV prophylaxis, click Synagis Uses. This article takes a closer look at this medicine, including who it is designed for, how it works, whether adults can use it, and more.)
5 Tips to Keep a Cold at Bay
Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2020 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.